Formulation pre-screening of inhalation powders using computational atom-atom systematic search method.
Vasuki Ramachandran1, Darragh Murnane, Robert B Hammond
1Institute of Particle Science and Engineering, Institute of Process Research and Development, School of Chemical and Process Engineering, University of Leeds , Leeds LS2 9JT, U.K.
Molecular Pharmaceutics
|November 8, 2014
Summary
Synthonic modeling accurately predicted the cohesivity of active pharmaceutical ingredients (APIs) like fluticasone propionate, budesonide, and salbutamol for inhalation powders. However, it showed limitations with excipients like α-lactose monohydrate due to complex hydrogen bonding.
Area of Science:
- Materials Science
- Pharmaceutical Science
- Computational Chemistry
Background:
- Synthonic modeling offers a molecule-centered understanding of crystal surface properties.
- This approach has been widely used to study crystallization processes.
Purpose of the Study:
- To evaluate the functional relevance of synthonic modeling in inhalation powder formulation.
- To assess the cohesivity of fluticasone propionate (FP), budesonide (Bud), salbutamol base (SB), and α-lactose monohydrate (LMH).
Main Methods:
- Synthonic modeling was employed to predict cohesive strengths of APIs and LMH.
- Cohesive strength measurements were performed using laser diffraction to determine the airflow pressure for complete dispersion (CPP).
- Aerosolization studies were conducted on FP-LMH blends.
Main Results:
- Synthonic modeling predicted FP to have higher cohesive strength than Bud or SB, correlating with CPP measurements.
- LMH exhibited the highest predicted cohesive strength, but its CPP value did not align with this prediction.
- High predicted adhesive forces between FP and LMH were observed, yet aerosolization showed FP agglomerates were not disrupted by LMH.
Conclusions:
- Synthonic engineering tools show potential for rapid pre-screening in drug formulation.
- Further understanding of hydrogen-bonded systems and agglomerate structure is needed for accurate modeling of excipients like LMH.
- The study highlights the applicability of synthonic modeling in pharmaceutical development while noting areas for refinement.
Keywords:
budesonidede-agglomerationfluticasone propionatein silico formulation designinhalation drug deliveryinter-particle interactionlaser diffractionmolecular and synthonic modelingpowder dispersion analysissalbutamolα-lactose monohydrate

